Upstream Bio UPB
NASDAQ UPB
$2.86 +0.04 (+1.24%)
As of: Oct 21, 2026 · 1:37 PM EDT

Upstream Bio (UPB) Shares Repurchased (2025)

Updated

Analysis

Upstream Bio (UPB) Shares Repurchased (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,134.17 Bn 1,102.76 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 615.84 Bn 534.36 Bn 17.26 Bn 221.00 Mn
3 AbbVie 500.69 Bn 473.80 Bn 12.70 Bn 9.00 Mn
4 Merck 367.34 Bn 321.72 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.07 Bn 234.75 Bn 12.86 Bn -
7 Amgen 235.51 Bn 190.91 Bn 7.24 Bn -
8 Gilead Sciences 190.60 Bn 164.80 Bn 6.22 Bn 355.00 Mn
9 Pfizer 169.37 Bn 116.02 Bn 10.94 Bn -
10 Upstream Bio 155.52 Mn -1.11 Bn -3.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 34,000.00
API Access

Upstream Bio Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=UPB&period=max&api_key=YOUR_API_KEY